• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

    83.67 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 280
    Open 83.67
    Bid (Size) 75.00 (400)
    Ask (Size) 85.00 (100)
    Prev. Close 83.67
    Today's Range 83.67 - 83.67
    52wk Range 49.00 - 117.33
    Shares Outstanding 115,926,629
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Corcept (CORT) Q3 2025 Earnings Call Transcript ↗
    Corcept (CORT) Q3 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings Intellectual Property
    News headline image
    Corcept Therapeutics Inc (NASDAQ:CORT) Presents a Strong Growth and Technical Breakout Case ↗
    Corcept Therapeutics (CORT) combines strong fundamentals, including robust revenue growth and a healthy balance sheet, with a positive technical breakout setup. 
    Via Chartmill

    Performance

    YTD
    +67.4%
    +67.4%
    1 Month
    +12.8%
    +12.8%
    3 Month
    +17.3%
    +17.3%
    6 Month
    +19.6%
    +19.6%
    1 Year
    +40.2%
    +40.2%

    More News

    Read More
    News headline image
    Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    CORCEPT THERAPEUTICS INC (NASDAQ:CORT): A Case Study in Affordable Growth Investing ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    1 Growth Stock with Explosive Upside and 2 We Brush Off
    Via StockStory
    News headline image
    Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Corcept (NASDAQ:CORT)
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
    Via StockStory
    Topics Artificial Intelligence Stocks
    News headline image
    The 5 Most Interesting Analyst Questions From Corcept’s Q3 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
    Via MarketMinute
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Peering Into Corcept Therapeutics Inc's Recent Short Interest ↗
    Via Benzinga
    News headline image
    CORT Q3 Deep Dive: Pharmacy Transition and Pipeline Expansion Drive Mixed Outlook
    Via StockStory
    News headline image
    Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q3 Earnings
    Via StockStory
    News headline image
    Corcept Therapeutics Announces Third Quarter Financial Results, Oncology Development Programs and Provides Corporate Update
    From Corcept Therapeutics Incorporated
    Via Business Wire
    News headline image
    Corcept Earnings: What To Look For From CORT
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Healthcare Stocks We Steer Clear Of
    Via StockStory
    Topics Stocks
    News headline image
    3 Cash-Producing Stocks with Open Questions
    Via StockStory
    News headline image
    Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
    From Corcept Therapeutics Incorporated
    Via Business Wire
    News headline image
    Beyond The Numbers: 6 Analysts Discuss Corcept Therapeutics Stock ↗
    Via Benzinga
    News headline image
    Corcept Therapeutics Stock Slips Premarket Despite Strong Cancer Trial Data Showing 40% Drop In Disease Progression Risk ↗
    Via Stocktwits
    News headline image
    Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment
    From Corcept Therapeutics Incorporated
    Via Business Wire
    News headline image
    1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm
    Via StockStory
    News headline image
    Corcept (CORT) Shares Skyrocket, What You Need To Know
    Via StockStory
    News headline image
    Corcept Submits Marketing Authorization Application to European Medicines Agency for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
    From Corcept Therapeutics Incorporated
    Via Business Wire
    News headline image
    3 High-Flying Stocks We Approach with Caution
    Via StockStory

    Frequently Asked Questions

    Is Corcept Therapeutics Incorporated - Common Stock publicly traded?
    Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.
    What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?
    Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?
    The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market
    What is the current price of Corcept Therapeutics Incorporated - Common Stock?
    The current price of Corcept Therapeutics Incorporated - Common Stock is 83.67
    When was Corcept Therapeutics Incorporated - Common Stock last traded?
    The last trade of Corcept Therapeutics Incorporated - Common Stock was at 12/03/25 04:00 PM ET
    What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?
    The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 9.70B
    How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?
    Corcept Therapeutics Incorporated - Common Stock has 10B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.